Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Thorpe

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Journal of Cellular Physiology|December 27, 2016
Smoothened-antagonists reverse homogentisic acid-induced alterations of Hedgehog signaling and primary cilium length in alkaptonuriaSilvia Gambassi, Michela Geminiani, Stephen D Thorpe, et al.
Journal of the National Cancer Institute|January 1, 2010
Assessing lead time of selected ovarian cancer biomarkers: a nested case-control studyGarnet L Anderson, Martin McIntosh, Lieling Wu, et al.
Cancer Immunology Research|April 26, 2014
JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitorsChris P Miller, Jason D Thorpe, Amanda N Kortum, et al.
European Journal of Medicinal Chemistry|June 5, 2025
Characterization of a water soluble quininib prodrug that blocks metabolic activity and proliferation of multiple cancer cell linesValentina Tonelotto, Alina Qaisar, Eavan C McLoughlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISANathalie Scholler, Kimberly A Lowe, Lindsay A Bergan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2009
Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125Chirag A Shah, Kimberly A Lowe, Pamela Paley, et al.
EMBO Reports|December 13, 2018
Tamoxifen mechanically reprograms the tumor microenvironment via HIF-1A and reduces cancer cell survivalErnesto Cortes, Dariusz Lachowski, Benjamin Robinson, et al.
Environmental Research|January 9, 2016
Environmental stress in the Gulf of Mexico and its potential impact on public healthB Singleton, J Turner, L Walter, et al.
Journal of the National Cancer Institute|September 16, 2011
Potential role of HE4 in multimodal screening for epithelial ovarian cancerNicole Urban, Jason D Thorpe, Lindsay A Bergan, et al.
Plos One|July 10, 2008
Systematic evaluation of candidate blood markers for detecting ovarian cancerChana Palmer, Xiaobo Duan, Sarah Hawley, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Journal of Cellular Physiology|December 27, 2016
Smoothened-antagonists reverse homogentisic acid-induced alterations of Hedgehog signaling and primary cilium length in alkaptonuriaSilvia Gambassi, Michela Geminiani, Stephen D Thorpe, et al.
Journal of the National Cancer Institute|January 1, 2010
Assessing lead time of selected ovarian cancer biomarkers: a nested case-control studyGarnet L Anderson, Martin McIntosh, Lieling Wu, et al.
Cancer Immunology Research|April 26, 2014
JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitorsChris P Miller, Jason D Thorpe, Amanda N Kortum, et al.
European Journal of Medicinal Chemistry|June 5, 2025
Characterization of a water soluble quininib prodrug that blocks metabolic activity and proliferation of multiple cancer cell linesValentina Tonelotto, Alina Qaisar, Eavan C McLoughlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISANathalie Scholler, Kimberly A Lowe, Lindsay A Bergan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2009
Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125Chirag A Shah, Kimberly A Lowe, Pamela Paley, et al.
EMBO Reports|December 13, 2018
Tamoxifen mechanically reprograms the tumor microenvironment via HIF-1A and reduces cancer cell survivalErnesto Cortes, Dariusz Lachowski, Benjamin Robinson, et al.
Environmental Research|January 9, 2016
Environmental stress in the Gulf of Mexico and its potential impact on public healthB Singleton, J Turner, L Walter, et al.
Journal of the National Cancer Institute|September 16, 2011
Potential role of HE4 in multimodal screening for epithelial ovarian cancerNicole Urban, Jason D Thorpe, Lindsay A Bergan, et al.
Plos One|July 10, 2008
Systematic evaluation of candidate blood markers for detecting ovarian cancerChana Palmer, Xiaobo Duan, Sarah Hawley, et al.
Pageof 11